“Promising” Trend: FDA Acts On Unapproved Drugs, Tainted Supplements
This article was originally published in The Tan Sheet
Executive Summary
U.S. Marshals' seizure of unapproved erectile dysfunction drugs from Shangai Distributors may be evidence of a promising trend of FDA following through on warning letters to companies marketing unapproved new drugs mislabeled as supplements, according to food and drug attorney Marc Ullman